CSF biomarkers and the diagnosis of variant forms of Alzheimer's disease

    loading  Checking for direct PDF access through Ovid

Abstract

The differential diagnosis of progressive neurodegenerative disorders may sometimes be challenging, despite longitudinal assessment and access to traditional modalities of structural and functional neuroimaging. In this article, the authors describe a patient tentatively diagnosed with corticobasal syndrome in whom investigation with cerebrospinal fluid biomarkers led to diagnostic revision and new therapeutic options.

Related Topics

    loading  Loading Related Articles